Abiopharma

News list

Catelani Michael 🟢 acquired 175.0K shares (1 derivative) of Anixa Biosciences Inc (ANIX) at $3.18 Transaction Date: Jan 05, 2026 | Filing ID: 000686

Full text

News bot Jan. 7, 2026, 12:56 a.m.
🔍 Catelani Michael (Executive)

Company: Anixa Biosciences Inc (ANIX)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 175,000
Detailed Transactions and Holdings:
- Acquired 175,000 shares of Employee Stock Option at $3.18 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2036-01-05 | equity_swap_involved: 0 | shares_owned_after: 175,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
- F2: The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026.